DEXCOM INC — Form 10-Q
Filed July 30, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 2/100
What the filing says
Jacob Leach (CEO) and Jereme Sylvain (CFO) issued standard Sarbanes-Oxley Section 302 and 18 U.S.C. §1350 certifications on July 30, 2026 for the Q2 2026 10-Q (quarter ended June 30, 2026), certifying that the report contains no material untrue statements, financial statements fairly present the company's condition and operations, and internal controls over financial reporting are designed and operating effectively. No material weaknesses, deficiencies, or fraud involving management were disclosed.
Why this rating
Routine executive certifications required by SOX and federal law; standard disclosure with no disclosed control issues or fraud.
See more from July 30, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.